These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3994344

  • 41. Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations.
    Zaske DE, Cipolle RJ, Rotschafer JC, Solem LD, Mosier NR, Strate RG.
    Antimicrob Agents Chemother; 1982 Mar; 21(3):407-11. PubMed ID: 7103444
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C, Danon A, Schlaeffer F, Reisenberg K, Alkan M, Smoliakov R, Sidi A, Almog Y.
    Am J Med; 2003 Feb 15; 114(3):194-8. PubMed ID: 12637133
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Aminoglycoside monitoring program.
    Vakoutis J, Stein GE, Miller PB, Clayman AE.
    Am J Hosp Pharm; 1981 Oct 15; 38(10):1477-80. PubMed ID: 7294041
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Gentamicin and tobramycin dosing guidelines: an evaluation.
    Matzke GR, Burkle WS, Lucarotti RL.
    Drug Intell Clin Pharm; 1983 Jun 15; 17(6):425-32. PubMed ID: 6861633
    [Abstract] [Full Text] [Related]

  • 48. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H, Grunert K, Kemmerich B, Koeppe P.
    Adv Clin Pharmacol; 1978 Jun 15; 15():35-44. PubMed ID: 676877
    [Abstract] [Full Text] [Related]

  • 49. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE, King JH.
    Ann Pharmacother; 2006 Jan 15; 40(1):9-14. PubMed ID: 16332944
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Comparative nephrotoxicity of two aminoglycosides: gentamicin and tobramycin.
    Weintraub RG, Duggin GG, Horvath JS, Tiller DJ.
    Med J Aust; 1982 Aug 07; 2(3):129-32. PubMed ID: 7121387
    [Abstract] [Full Text] [Related]

  • 52. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL, Tschida SJ, Rotschafer JC, Guay DR, Vance-Bryan K.
    J Burn Care Rehabil; 1997 Aug 07; 18(2):116-24. PubMed ID: 9095420
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Development and implementation of simplified aminoglycoside empiric dosing guidelines.
    Reesor Nimmo C, Mamdani F, Baker A, Jewesson P.
    Pharmacotherapy; 1993 Aug 07; 13(4):408-14. PubMed ID: 8361871
    [Abstract] [Full Text] [Related]

  • 57. Gentamicin and tobramycin penetration into synovial fluid.
    Dee TH, Kozin F.
    Antimicrob Agents Chemother; 1977 Oct 07; 12(4):548-9. PubMed ID: 921252
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Prediction of serum gentamicin concentrations in patients undergoing hemodialysis.
    Goetz DR, Pancorbo S, Hoag S, Bloom P.
    Am J Hosp Pharm; 1980 Aug 07; 37(8):1077-83. PubMed ID: 7405935
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.